Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT2020 in Hospitalized COVID-19 Patients
NCT04432766Phase 2Withdrawn
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BAT2020 in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Bio-Thera Solutions, Ltd. Primary endpoint: Incidence of adverse events at Day 28. Planned start Oct 2020; status: withdrawn.
02
Drugs
BAT2020
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04432766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432766.